145 related articles for article (PubMed ID: 36974371)
1. Synthesis, structures, reactivity and medicinal chemistry of antitubercular benzothiazinones.
Seidel RW; Richter A; Goddard R; Imming P
Chem Commun (Camb); 2023 Apr; 59(32):4697-4715. PubMed ID: 36974371
[TBL] [Abstract][Full Text] [Related]
2. New Insight into Dearomatization and Decarbonylation of Antitubercular 4H-Benzo[e][1,3]thiazinones: Stable 5H- and 7H-Benzo[e][1,3]thiazines.
Richter A; Seidel RW; Graf J; Goddard R; Lehmann C; Schlegel T; Khater N; Imming P
ChemMedChem; 2022 Mar; 17(6):e202200021. PubMed ID: 35170242
[TBL] [Abstract][Full Text] [Related]
3. Identification of benzothiazinones containing an oxime functional moiety as new anti-tuberculosis agents.
Wang A; Lv K; Tao Z; Gu J; Fu L; Liu M; Wan B; Franzblau SG; Ma C; Ma X; Han B; Wang A; Xu S; Lu Y
Eur J Med Chem; 2019 Nov; 181():111595. PubMed ID: 31408806
[TBL] [Abstract][Full Text] [Related]
4. Design, synthesis and antitubercular evaluation of benzothiazinones containing a piperidine moiety.
Lv K; Tao Z; Liu Q; Yang L; Wang B; Wu S; Wang A; Huang M; Liu M; Lu Y
Eur J Med Chem; 2018 May; 151():1-8. PubMed ID: 29601990
[TBL] [Abstract][Full Text] [Related]
5. Synthesis and Biological Activity of 2-Amino- and 2-aryl (Heteryl) Substituted 1,3-Benzothiazin-4-ones.
Nosova EV; Lipunova GN; Charushin VN; Chupakhin ON
Mini Rev Med Chem; 2019; 19(12):999-1014. PubMed ID: 30324881
[TBL] [Abstract][Full Text] [Related]
6. The 8-Pyrrole-Benzothiazinones Are Noncovalent Inhibitors of DprE1 from Mycobacterium tuberculosis.
Makarov V; Neres J; Hartkoorn RC; Ryabova OB; Kazakova E; Šarkan M; Huszár S; Piton J; Kolly GS; Vocat A; Conroy TM; Mikušová K; Cole ST
Antimicrob Agents Chemother; 2015 Aug; 59(8):4446-52. PubMed ID: 25987616
[TBL] [Abstract][Full Text] [Related]
7. Towards a new combination therapy for tuberculosis with next generation benzothiazinones.
Makarov V; Lechartier B; Zhang M; Neres J; van der Sar AM; Raadsen SA; Hartkoorn RC; Ryabova OB; Vocat A; Decosterd LA; Widmer N; Buclin T; Bitter W; Andries K; Pojer F; Dyson PJ; Cole ST
EMBO Mol Med; 2014 Mar; 6(3):372-83. PubMed ID: 24500695
[TBL] [Abstract][Full Text] [Related]
8. Benzothiazinones kill Mycobacterium tuberculosis by blocking arabinan synthesis.
Makarov V; Manina G; Mikusova K; Möllmann U; Ryabova O; Saint-Joanis B; Dhar N; Pasca MR; Buroni S; Lucarelli AP; Milano A; De Rossi E; Belanova M; Bobovska A; Dianiskova P; Kordulakova J; Sala C; Fullam E; Schneider P; McKinney JD; Brodin P; Christophe T; Waddell S; Butcher P; Albrethsen J; Rosenkrands I; Brosch R; Nandi V; Bharath S; Gaonkar S; Shandil RK; Balasubramanian V; Balganesh T; Tyagi S; Grosset J; Riccardi G; Cole ST
Science; 2009 May; 324(5928):801-4. PubMed ID: 19299584
[TBL] [Abstract][Full Text] [Related]
9. Synthesis and antitubercular evaluation of 4-carbonyl piperazine substituted 1,3-benzothiazin-4-one derivatives.
Peng CT; Gao C; Wang NY; You XY; Zhang LD; Zhu YX; Xv Y; Zuo WQ; Ran K; Deng HX; Lei Q; Xiao KJ; Yu LT
Bioorg Med Chem Lett; 2015 Apr; 25(7):1373-6. PubMed ID: 25754492
[TBL] [Abstract][Full Text] [Related]
10. Characterization of DprE1-Mediated Benzothiazinone Resistance in Mycobacterium tuberculosis.
Foo CS; Lechartier B; Kolly GS; Boy-Röttger S; Neres J; Rybniker J; Lupien A; Sala C; Piton J; Cole ST
Antimicrob Agents Chemother; 2016 Nov; 60(11):6451-6459. PubMed ID: 27527085
[TBL] [Abstract][Full Text] [Related]
11. Thiolates chemically induce redox activation of BTZ043 and related potent nitroaromatic anti-tuberculosis agents.
Tiwari R; Moraski GC; Krchňák V; Miller PA; Colon-Martinez M; Herrero E; Oliver AG; Miller MJ
J Am Chem Soc; 2013 Mar; 135(9):3539-49. PubMed ID: 23402278
[TBL] [Abstract][Full Text] [Related]
12. Identification of benzothiazinones containing 2-benzyl-2,7-diazaspiro[3.5]nonane moieties as new antitubercular agents.
Wang A; Ma C; Chai Y; Liu X; Lv K; Fu L; Wang B; Jia X; Liu M; Lu Y
Eur J Med Chem; 2020 Aug; 200():112409. PubMed ID: 32460114
[TBL] [Abstract][Full Text] [Related]
13. Synthesis and structure-activity relationships evaluation of benzothiazinone derivatives as potential anti-tubercular agents.
Gao C; Ye TH; Wang NY; Zeng XX; Zhang LD; Xiong Y; You XY; Xia Y; Xu Y; Peng CT; Zuo WQ; Wei Y; Yu LT
Bioorg Med Chem Lett; 2013 Sep; 23(17):4919-22. PubMed ID: 23886691
[TBL] [Abstract][Full Text] [Related]
14. Benzothiazinones: prodrugs that covalently modify the decaprenylphosphoryl-β-D-ribose 2'-epimerase DprE1 of Mycobacterium tuberculosis.
Trefzer C; Rengifo-Gonzalez M; Hinner MJ; Schneider P; Makarov V; Cole ST; Johnsson K
J Am Chem Soc; 2010 Oct; 132(39):13663-5. PubMed ID: 20828197
[TBL] [Abstract][Full Text] [Related]
15. [Effect of physicochemical properties on the pharmacokinetic parameters of the new representative of benzothiazinones antituberculosis drug macozinonе].
Khokhlov AL; Mariandyshev AO; Shcherbakova VS; Ozerova IV; Kazaishvili YG; Igumnova OV; Bolgarina AA; Rudoy BA
Ter Arkh; 2020 Dec; 92(12):165-171. PubMed ID: 33720590
[TBL] [Abstract][Full Text] [Related]
16. Synthesis, structural characterization and antimycobacterial evaluation of several halogenated non-nitro benzothiazinones.
Madikizela B; Eckhardt T; Goddard R; Richter A; Lins A; Lehmann C; Imming P; Seidel RW
Med Chem Res; 2021; 30(8):1523-1533. PubMed ID: 34131377
[TBL] [Abstract][Full Text] [Related]
17. Design, synthesis and antitubercular activity of novel N-(amino)piperazinyl benzothiazinones with improved safety.
Wang A; Du N; Song H; Zhang Y; Zhong X; Wu J; Xue T; Liu M; Wang B; Lv K; Lu Y
Eur J Med Chem; 2023 Oct; 258():115545. PubMed ID: 37300914
[TBL] [Abstract][Full Text] [Related]
18. Design, syntheses, and anti-tuberculosis activities of conjugates of piperazino-1,3-benzothiazin-4-ones (pBTZs) with 2,7-dimethylimidazo [1,2-a]pyridine-3-carboxylic acids and 7-phenylacetyl cephalosporins.
Majewski MW; Tiwari R; Miller PA; Cho S; Franzblau SG; Miller MJ
Bioorg Med Chem Lett; 2016 Apr; 26(8):2068-71. PubMed ID: 26951749
[TBL] [Abstract][Full Text] [Related]
19. Mutations in
Poulton NC; Azadian ZA; DeJesus MA; Rock JM
Antimicrob Agents Chemother; 2022 Sep; 66(9):e0090422. PubMed ID: 35920665
[TBL] [Abstract][Full Text] [Related]
20. In vitro and in vivo antimicrobial activities of a novel piperazine-containing benzothiazinones candidate TZY-5-84 against Mycobacterium tuberculosis.
Guo S; Fu L; Wang B; Chen X; Zhao J; Liu M; Lu Y
Biomed Pharmacother; 2020 Nov; 131():110777. PubMed ID: 33152936
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
